An independent not-for-profit 501(c)(6) trade association serving and representing the life sciences industry in northern Texas, BioNorth Texas’ mission is to encourage development of a rich, biotechnology-focused ecosystem for promoting growth and success of North Texas life science companies, as well as strengthening the economy of the region’s local communities, making the region a leading life science market, and demonstrating potential for North Texas to become a leading cluster in bioscience innovation and a sought after place to work and live.
Conceived and created to productively assist participant members with development of ecosystem changing initiatives that benefit the whole industry in the North Texas region, the industry-driven organization seeks to highlight North Texas life sciences successes and assets, including academic research, member organizations activities and goals, and available resources. Membership includes both organizations and individuals engaged in, or supportive of, research, development and commercialization of life science technologies.
In support of BioNorth Texas’ mission, the organization’s inaugural BioNorthTX iC3 Life Science Summit was held Wednesday, Sept. 30, at the Dallas Marriott Las Colinas hotel in Irving, Texas, with a program of networking, education and business development conferences for investors, researchers and life science companies.
Both emerging and established life science, biopharma, pharma, and healthcare companies as well as academic research institutions, innovators and industry leaders attended the iC3 Summit, as well as business development executives, vendor partners, investors, and other biotech business professionals interested in expanding their business in the North Texas region.
The Summit program was kicked-off with an opening plenary session breakfast featuring a keynote address by The Honorable James Greenwood, CEO of the Washington, DC based Biotechnology Industry Organization, which represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
Keynotes were also delivered by Tom Kowalski, CEO and President of the Texas Healthcare and Bioscience Institute (THBI), in Austin, and Dr. Dennis Stone MD, Chief Scientific Officer and Director of Remeditex in Dallas. Morning sessions were followed with a lunch keynote on the 30th by Allan May, founder and chairman of Life Science Angels, Inc., the largest angel organization in the U.S. focused solely on early stage medical device and life science start-ups, along with an audience of high net worth individuals from the medical device or biotech fields.
Other Summit highlights included a North Texas company CEO panel, in which key opinion leaders discussed their companies’ operational strategies and successes, and a North Texas research organizations showcase with exhibit booths from key regional support organizations accessible to attendees. Job seekers and post docs also had the opportunity to interact with potential hiring executives during the summit, which closed with a cocktail reception for attendees.
The iC3 Summit followed-up a Breakfast Forum event held August 31 hosted by founding member organization Baylor Research Institute (BRI) — a Dallas-based research center dedicated to researching and developing patient-focused prevention therapies and treatments for diseases and illnesses. Two BRI employees who also served on the iC3 Life Sciences Summit planning committee are Jaime Walkowiak, vice president of clinical research operations who leads Baylor Research Institute’s clinical research activities and development programs with an emphasis on professionalism and quality of support to principal investigators, and Melissa Acosta, PhD, a patent liaison in the Intellectual Property Protection Office whose work includes patents relating to Microfluidic devices, anti-viral vaccines for diseases such as Rotavirus and Norwalk virus, cancer therapeutics and therapeutic methods using nucleic acid compositions, protein compositions or other small molecule compositions. As BRI’s patent liaison, Dr. Acosta is responsible for the management and administrative oversight of BRI’s entire patent portfolio.
Membership in BioNorthTX, which held its first Board of Directors meeting at The Foundry in Dallas in April, 2015, includes companies and organizations working in fields that include: Biotechnology, Medical Device & Equipment, Pharmaceuticals & Therapeutics, Nanotechnology, Agricultural Biotechnology, and Product Development/Drug Discovery Firms. A full list of BioNorthTX partners can be found at: http://bionorthtx.org/members/
BioNorthTX is dedicated to filling a major gap in the North Texas biotech and life sciences industries by promoting the convergence of life science research and supporting industries. One of the annual iC3 Summit goals is providing a forum for life science (biotechnology, medical device, pharmaceutical) company executives, academic professionals, investors, and industry support organizations, and an opportunity to meet in one place as part of the regions largest annual conference bringing together all regional industry participants, and to raise awareness among regional businesses at large of North Texas’s potential to become a leader in bioscience innovation.
The iC3 Summit could not be held without generous support of members and sponsors. As a newly formed non-profit, BioNorthTX relies on this support and offers several levels of opportunities to participate. For more sponsorship information, email info(at)bionorthtx.org.
For more information visit:
Baylor Research Institute